In addition, the eight−gene signature derived from the GPRC5A+ program stratified survival not only in TCGA−LUAD but also in two independent NSCLC/LUAD cohorts (GSE30219 and GSE31210). This evidence concerns the gene GPRC5A and non-small cell lung carcinoma.